# Crystalys Therapeutics funding rounds and investors

As of 14 Oct 2026, Crystalys Therapeutics has raised $205M across 1 verified round on record; latest: $205 million Series A led by Catalys Pacific, Novo Holdings and 1 other, announced 30 Sep 2025.

Crystalystx develops therapeutics specifically for treating gout.

Website: https://crystalystx.com  
Headquarters: San Diego, California  
Page: https://fireround.dev/companies/crystalystx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-09-30 | Series A | $205 million | Catalys Pacific, Novo Holdings, SR One | abrdn, Alexandria Venture Investments, AN Venture Partners, KB Investment, Lightstone Ventures, Longwood Fund, Perceptive Xontogeny Venture Funds (PXV Funds), Pontifax, Prebys Ventures, Wedbush Healthcare Partners | [prnewswire.com](https://www.prnewswire.com/news-releases/crystalys-therapeutics-launches-with-205m-series-a-financing-to-transform-the-treatment-of-gout-302569747.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.